Genome sequencing analyzes and records genetic markers across an individual’s genome. This analytical technology can help patients learn about their family history, their risk levels for certain diseases, and their likely responses to a variety of drug treatments. In recent years, the cost for DNA sequencing has dramatically decreased.
There is still much to learn when comparing genome information against known diseases, so physicians cannot provide their patients a complete risk profile just yet. However, researchers are now taking advantage of the reductions in cost and processing time to gather more knowledge on common diseases such as diabetes, obesity, and depression.
Marylyn Ritchie, PhD
Senior Investigator & Founding Director: Biomedical & Translational Informatics Program
Geisinger Health System